Company Profile
Delcath Systems Stock Price, News & Analysis
- Ticker:
- DCTH
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Delcath Systems is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
12.29 USD (+6.78%)
Close
Last updated: June 23, 2026 at 00:00
424.27M USD
Market cap
Why the stock is moving
DCTH is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Delcath Systems is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Delcath Systems is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Delcath Systems follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Delcath Systems sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts
Source: Delcath Systems
- 02
- 03
Delcath Systems Reports First Quarter 2026 Results and Business Highlights
Source: Delcath Systems
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Delcath Systems (DCTH)?
Delcath Systems (DCTH) most recently closed at 12.29 USD, a +6.78% move versus the previous session.
What is the market cap of Delcath Systems (DCTH)?
Delcath Systems currently has a market capitalization of 424.27M USD on BioPharmSignal.
What does Delcath Systems do?
Delcath Systems is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is DCTH stock listed?
Delcath Systems (DCTH) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Delcath Systems is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Delcath?
Delcath Systems is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Delcath Systems targeting with Delcath?
Delcath Systems is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Systems?
Delcath Systems is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.